Myositis Ossificans: all 25 studies

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)Not yet recruitingNCT07559513Phase 3
• IL1 Inhibition in FOPRecruitingNCT06724562
• A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)RecruitingNCT06089616
• To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans ProgressivaRecruitingNCT05090891Phase 2
• The Fibrodysplasia Ossificans Progressiva (FOP) RegistryRecruitingNCT02745158
• A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.CompletedNCT05027802Phase 3Results posted
• An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.CompletedNCT03312634Phase 3Results posted
• A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans ProgressivaCompletedNCT03188666Phase 2Results posted
• In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) SubjectsTerminatedNCT02521792Phase 2Results posted
• An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)CompletedNCT02279095Phase 2Results posted
• An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP SubjectsCompletedNCT02190747Phase 2Results posted
• An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)Approved for marketingNCT07301450
• A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)Active, not recruitingNCT06508021Phase 2/3
• Comparative Analysis of Radiotherapeutic and Medical Procedures for the Prophylaxis of Heterotopic OssificationsCompletedNCT06251349
• A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)CompletedNCT06064656
• A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)Active, not recruitingNCT05394116Phase 3
• A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).TerminatedNCT05039515Phase 2
• Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult SubjectsCompletedNCT04829773Phase 1
• Study of Single-Ascending Doses of DS-6016a in Healthy Japanese SubjectsCompletedNCT04818398Phase 1
• An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.CompletedNCT04665323
• Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)WithdrawnNCT04577820Phase 3
• Saracatinib Trial TO Prevent FOPActive, not recruitingNCT04307953Phase 2
• Comparison Between CT and MRI in Preoperative Evaluation of Neurogenic Myositis Ossificans or Neurogenic Para-osteo-arthritisCompletedNCT03832556Not applicable
• A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)CompletedNCT02322255
• Urine Sample Collection From FOP PatientsCompletedNCT02066324

← Myositis Ossificans overview